carbidopa monohydrate at a glance
Medicine class
Peripheral dopa-decarboxylase inhibitor supplied with levodopa.
Usual role
Relieves symptoms of Parkinson's disease and parkinsonian syndromes as part of co-careldopa.
What is carbidopa monohydrate used for?
The selected product is licensed as an antiparkinsonian treatment.
Parkinson's disease
Parkinsonian syndromes; it is not recommended for movement problems caused by medicines
How does carbidopa monohydrate work?
Levodopa crosses into the brain and is converted into dopamine, helping movement-related nerve signals. Carbidopa acts mainly outside the brain, preventing levodopa from being converted too early. This increases levodopa availability and reduces peripheral effects such as nausea.
How to take carbidopa monohydrate
The selected product is an immediate-release oral tablet.
A protein-heavy meal can reduce levodopa absorption in some people; discuss food-related changes in symptom control with the Parkinson's team.
If a tablet breaks while being removed from its packaging, take it only if every piece is present; otherwise use an intact tablet.
Immediate-release tablets may be dispersed in water or mixed with a small amount of soft food when professionally directed; this is off-label. Modified-release tablets must not be crushed.
carbidopa monohydrate side effects
Common or expected effects
- Nausea, vomiting, reduced appetite, dry mouth or bitter taste
- Dizziness, sleepiness, fatigue, disturbed sleep or vivid dreams
- Involuntary movements
- Hallucinations or confusion
- Light-headedness on standing
- Palpitations or an irregular heartbeat
Get urgent medical advice
- Seek prompt assessment for new hallucinations, delusions, severe depression or major behavioural changes.
- Tell the prescriber promptly about compulsive gambling, spending, eating or sexual behaviour, or craving excessive amounts of treatment.
- Stop driving and seek medical advice for sudden sleep episodes or severe daytime sleepiness.
- Seek urgent help for allergic swelling or breathing difficulty, collapse, significant chest symptoms, gastrointestinal bleeding, or fever, rigidity and confusion after withdrawal.
carbidopa monohydrate in pregnancy
Co-careldopa is not recommended during pregnancy unless the expected maternal benefit outweighs the possible fetal risk. Obtain specialist advice if pregnant or planning pregnancy, and do not stop Parkinson's treatment abruptly.
carbidopa monohydrate while breastfeeding
The selected product information advises stopping breastfeeding during treatment. Levodopa enters human milk, while information about carbidopa exposure and effects in breastfed infants is insufficient. Discuss feeding options with the specialist team.
carbidopa monohydrate interactions
Check all prescribed, non-prescribed and complementary products with a pharmacist or prescriber.
Non-selective MAO inhibitors and selective MAO-A inhibitors
The combination is contraindicated because serious cardiovascular reactions may occur; recent use requires prescriber review.
Iron preparations
Iron can reduce carbidopa or levodopa availability. Seek professional advice about separating administration.
Antihypertensive medicines
May worsen postural hypotension, causing dizziness or fainting.
Common questions about carbidopa monohydrate
Answers are fully visible for fast scanning and source review.
Is carbidopa monohydrate the same as co-careldopa?
Carbidopa monohydrate is the form of carbidopa in co-careldopa; co-careldopa combines carbidopa with levodopa.
Can it treat Parkinson's disease by itself?
No. It supports levodopa by reducing its breakdown outside the brain.
Which symptoms can co-careldopa improve?
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.